Navigation Links
The Astellas European Foundation Winner of Transplantation Grant 2011 Announced
Date:9/6/2011

GLASGOW, Scotland, September 7, 2011 /PRNewswire/ --

The Astellas European Foundation is delighted to announce the winner of the 2011 Transplantation Grant:

Dr Christian Toso of the University of Geneva, Switzerland

Last evening, the University's team, led by Dr Toso, received the grant of US$ 300,000 to support work on their project entitled 'Towards a tailored immuno-suppression after liver transplantation for hepatocellular carcinoma' at the Astellas European Foundation Award presentation.

Dr Ayad Abdulahad, Astellas European Foundation Trustee and Vice President Medical Affairs and Health Economics for Astellas Pharma Europe Ltd. commented, "We received many entries of a very high standard which covered a broad range of topics across Europe.  In the face of very strong competition the Jury chose Dr Toso's research based on its potential impact on clinical practice.  The team's aim is to tailor immunosuppressive strategy for individual patients with hepatocellular carcinoma. It is very exciting and, in the future, their results could possibly be applied to other cancers."

At the Award Presentation Event in Glasgow, UK, the Astellas European Foundation emphasised their continued and long term commitment to research and development in the field of transplant medicine.

Dr Toso said, "We thank the Astellas European Foundation for its generous support. Although liver transplantation is the most efficient treatment for patients with early  unresectable hepatocellular carcinoma, some 10% of recipients still experience recurrence after transplantation. The aim of our study is to define the ideal immunosuppression strategy, both clearing cancer cells and preventing rejection. Such a study has the potential to better tailor immunosuppression after liver transplantat
'/>"/>

SOURCE Astellas European Foundation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Astellas and Medivation Enter Into Worldwide Agreement to Co-Develop and Co-Commercialize MDV3100 for the Treatment of Prostate Cancer
2. Ironwood and Astellas Announce Japan Licensing Agreement for Linaclotide
3. Emerging Agents from Theravance/Astellas, Johnson & Johnson/Basilea and Forest/Astrazeneca/Takeda Will Drive Modest Growth in the MRSA Drug Market Through 2018
4. Ambit Biosciences and Astellas Enter Strategic Partnership to Research, Develop and Commercialize FLT3 Kinase Inhibitors in Multiple Indications
5. Astellas Announces Full Slate of Independent Director Nominees for Election at OSI Pharmaceuticals 2010 Annual Stockholders Meeting
6. Astellas Announces Successful Completion of Initial Tender Offer for Shares of OSI and Announces Subsequent Offer Period
7. Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical Trial of AGS-16M8F for Renal Cancer
8. Astellas Awards Scholarships to 12 Transplant Recipients and Donors Who Embody Hope, Courage and Achievement
9. Astellas Mobilizes 1,300+ Employees in the Americas to Participate in First Annual Changing Tomorrow Day
10. Although NeurogesX/Astellass Qutenza is Only Approved for Postherpetic Neuralgia, Surveyed U.S. Physicians are Likely to Prescribe It for All Neuropathic Pain Types
11. Astellas Announces Retirement of Donald Rice and Appointment of Sef Kurstjens as CEO and President of Agensys, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/18/2014)... 18, 2014  ADM Tronics Unlimited, Inc. (OTCQB: ... to its corporate Advisory Board for business development. ... the Harvard Medical School and Visiting Professor at ... his Masters degree in Electronics Engineering and his ... of Bologna. After spending a year as a ...
(Date:9/18/2014)... 18, 2014  ePharmaSolutions, the leading provider ... the Disruptive Innovator of the Year at ... platform. This solution includes an integrated clinical ... (eTMF), a remote monitoring application, eSource and ... screening and matching technology. The ...
(Date:9/18/2014)... , Sept. 18, 2014  Zacks.com announces the ... day the Zacks Equity Research analysts discuss the latest ... Stocks recently featured in the blog include the Avanir Pharmaceuticals ... (Nasdaq: NPSP - Free Report ), Orexigen (Nasdaq: ... MDVN - Free Report ) and Gilead (Nasdaq: ...
Breaking Medicine Technology:ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 2ADM Tronics Appoints Gianluca DeNovi, Ph.D. To Advisory Board 3ePharmaSolutions Named 2014 Disruptive Innovator of the Year for its ePharmaONE eClinical Platform 2ePharmaSolutions Named 2014 Disruptive Innovator of the Year for its ePharmaONE eClinical Platform 3The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 2The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 3The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 4The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 5The Zacks Analyst Blog Highlights: Avanir Pharmaceuticals, NPS Pharmaceuticals, Orexigen, Medivation and Gilead 6
... United Arab Emirates, Sept. 22 NewBridge Pharmaceuticals announced ... agreement with Orexo AB (STO: ORX) that grants NewBridge ... treatment of breakthrough cancer pain, in the Middle East ... and sell the product in these territories.  The agreement ...
... Decision Resources, one of the world,s leading research and ... to generic erosion of key agents, the colorectal cancer drug ... from more than $6.4 billion in 2009 to just under ... Italy, Spain, United Kingdom and Japan. The Pharmacor ...
Cached Medicine Technology:NewBridge Pharmaceuticals Signs Agreement for Abstral™ for the Middle East and Africa 2NewBridge Pharmaceuticals Signs Agreement for Abstral™ for the Middle East and Africa 3NewBridge Pharmaceuticals Signs Agreement for Abstral™ for the Middle East and Africa 4Owing to Generic Erosion of Key Agents, the Colorectal Cancer Drug Market Will Remain Relatively Flat Through 2019 2Owing to Generic Erosion of Key Agents, the Colorectal Cancer Drug Market Will Remain Relatively Flat Through 2019 3
(Date:9/18/2014)... 2014 “Awesome” is the way Emily ... Accepting Responsibility Today) Internship Program at ARDX ( http://www.ardx.net ... describe the program as “Inspirational” and “Life-changing,” respectively. ... what they would be doing during their summer internship. ... runs and other mindless tasks,” but, instead she was ...
(Date:9/18/2014)... September 18, 2014 T-System Inc. ... electronic physician documentation system — EV™ for ... , After assessing several best-of-breed solutions, Holyoke chose ... with optimizing physician productivity and reimbursement, but also ... which will still be used to capture emergency ...
(Date:9/18/2014)... By Maureen Salamon ... (HealthDay News) -- Migraines in midlife may be associated ... movement disorders in later years, new research suggests. ... between the two brain-based conditions, also suggested that the ... by aura. An aura is a warning sign of ...
(Date:9/18/2014)... Chino Hills, CA (PRWEB) September 18, 2014 ... boot camp, is the fastest-selling fitness business in the country ... to work out, has continued to grow enormously in 2014. ... Boot Camp World Conference, is taking place in Costa Mesa, ... be one of the biggest conferences yet. Founder Bedros Keuilian, ...
(Date:9/18/2014)... How much is a serving? ... factors contributing to the obesity epidemic in the United ... and how to manage portion size during the next ... at Humility House, 755 Ohltown Road, Austintown. , Registered ... informational discussion and answer questions from 12:30 to 2 ...
Breaking Medicine News(10 mins):Health News:ARDX Internship Helps Students to START on the Right Business Path 2Health News:ARDX Internship Helps Students to START on the Right Business Path 3Health News:ARDX Internship Helps Students to START on the Right Business Path 4Health News:Holyoke Medical Center ER Improves Productivity and Reimbursement with T-System 2Health News:Are Migraines in Middle Age Tied to Raised Parkinson's Risk Later? 2Health News:Are Migraines in Middle Age Tied to Raised Parkinson's Risk Later? 3Health News:With Fit Body Boot Camp World Conference Nearing, Founder Explains the Fitness Boot Camp Franchise’s Success 2Health News:With Fit Body Boot Camp World Conference Nearing, Founder Explains the Fitness Boot Camp Franchise’s Success 3Health News:HMHP Workshop Addresses Portion Control 2
... Improve Health, MADISON, Wis., June 2 The ... now studies have linked poor,indoor air quality to the ... also a variety of other health issues, including heart,disease, ... prove poor indoor air quality can cause or,contribute to ...
... 15% of their daily calories, study finds , , MONDAY, June ... more sugary beverages and fruit juices than ever before, a ... now take in up to 15 percent of their total ... confirms previous research and suggests consumption is rising. , It,s ...
... papers outlining the progress made on the ... being published in the June 2008 issue ... Written by experts representing the global ... scientific and technological approaches to implementing ICH* ...
... in Pediatrics and led by researchers at Columbia University ... (SSBs) are an increasingly large part of children and ... sodas, fruit drinks and punches, and sports drinks, drink ... increase from 10 years earlier. The findings suggest ...
... June 2 Medical Simulation Corporation (MSC),announces ... Foundation (SSF) to,provide simulation training and education ... at the SSF world-class,training facility in Seattle, ... training in surgical and endovascular,procedures, using didactic ...
... to its growing family of CCRCs with expansion ... WEST POINT, Pa., June 2 ACTS Retirement-Life,Communities, ... it has completed its acquisition of Carlton Cove, ... The,community will be renamed Magnolia Trace and become ...
Cached Medicine News:Health News:Studies Find Poor Indoor Air Quality Can Lead to Major Health Problems 2Health News:Studies Find Poor Indoor Air Quality Can Lead to Major Health Problems 3Health News:Kids Gulping Down More Sugary Beverages 2Health News:Kids Gulping Down More Sugary Beverages 3Health News:Reshaping pharmaceutical quality 2Health News:Children's consumption of sugar-sweetened beverages 2Health News:Children's consumption of sugar-sweetened beverages 3Health News:Medical Simulation Corporation Announces Partnership With Seattle Science Foundation 2Health News:ACTS Retirement-Life Communities Completes Carlton Cove Acquisition 2
Daubenspeck sharp curette, 8....
Bruns bone curette, 9, oval, solid actagonal handle....
MRI curette, 8.5" overall length....
15" overall length, 5" handle....
Medicine Products: